独立董事制度发展与优化——从康美药业案出发Development and Optimization of the Independent Director System—Starting from the Kangmei Pharmaceutical Case
蒋哲诚 下载量: 279 浏览量: 412
法学 Vol.11 No.6, November 24 2023, PDF, HTML, XML DOI:10.12677/OJLS.2023.116891 被引量
我国上市公司独立董事制度的反思与完善路径Reflection and Improvement Path of Independent Director System of Listed Companies in China
吴轶雯 下载量: 204 浏览量: 343
法学 Vol.11 No.6, November 27 2023, PDF, HTML, XML DOI:10.12677/OJLS.2023.116902 被引量
从康美药业虚假陈述案看我国独立董事制度改进与重构 The Improvement and Reconstruction of China’s Independent Director System from the Case of Kangmei Pharmaceutical’s False Statement
席敏智 下载量: 340 浏览量: 1,300
争议解决 Vol.9 No.6, November 22 2023, PDF, HTML, XML DOI:10.12677/DS.2023.96452 被引量
我国独立董事违反勤勉义务的认定标准问题探究An Exploration of the Criteria for Determining the Violation of the Duty of Diligence by Independent Directors in China
房 燕 下载量: 126 浏览量: 234 科研立项经费支持
法学 Vol.12 No.3, March 29 2024, PDF, HTML, XML DOI:10.12677/ojls.2024.123265 被引量
虚假陈述中独立董事民事责任研究 Research on the Civil Liability of Independent Directors in False Statement
刘 畅 下载量: 367 浏览量: 1,666
争议解决 Vol.9 No.2, March 7 2023, PDF, HTML, XML DOI:10.12677/DS.2023.92053 被引量
公司治理结构下中小股东权益保护 Protection of Minority Shareholders’ Rights and Interests under Corporate Governance Structure
韦 昕 下载量: 310 浏览量: 843
争议解决 Vol.9 No.1, January 28 2023, PDF, HTML, XML DOI:10.12677/DS.2023.91029 被引量